Abstract

Unraveling the Impact of 177Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Real-World Data Analysis of Efficacy and Survival After Lutetium-177 Labelled PSMA Ligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
Danielle Meyrick ... Marat Gallyamov
Targeted oncology | VOL. 16
Danielle Meyrick, et. al.Danielle Meyrick ... Marat Gallyamov
09 Mar 2021
Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer in Germany: Population-based data with multicenter validation from 2016 to 2020.
Luka Flegar ... Hendrik Heers
Journal of Clinical Oncology | VOL. 41
Luka Flegar, et. al.Luka Flegar ... Hendrik Heers
20 Feb 2023
Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects.
Valentina Fuoco ... Marco Maccauro
Tumori | VOL. 108
Valentina Fuoco, et. al.Valentina Fuoco ... Marco Maccauro
18 Aug 2021
Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function.
Florian Rosar ... Stephan Maus
Cancers | VOL. 13
Florian Rosar, et. al.Florian Rosar ... Stephan Maus
21 Jun 2021
View more papers

More From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Paper Title
Journal
Date
Author
Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.
Lukas Kessler ... Hubertus Hautzel
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Lukas Kessler, et. al.Lukas Kessler ... Hubertus Hautzel
03 Jul 2024
An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity.
Julia Brosch-Lenz ... Carlos Uribe
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Julia Brosch-Lenz, et. al.Julia Brosch-Lenz ... Carlos Uribe
03 Jul 2024
Dosimetry of [177Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis.
Zachary Ells ... Jeremie Calais
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Zachary Ells, et. al.Zachary Ells ... Jeremie Calais
03 Jul 2024
Performing [18F]MFBG Long-Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma.
Lise Borgwardt ... Barbara Malene Fischer
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Lise Borgwardt, et. al.Lise Borgwardt ... Barbara Malene Fischer
03 Jul 2024
View more papers